Real-world benefits found with hydroxyurea for sickle cell children

Real-world benefits found with hydroxyurea for sickle cell children

Long-term treatment with hydroxyurea reduces emergency department visits and days spent in the hospital for children with sickle cell anemia, the most common and usually the most severe form of sickle cell disease (SCD), a real-world study has found. Consistent benefits among pediatric patients given the approved medication were seen for up to 12 years, according to the researchers. “This is one of the first large, real-world, long-term studies …